Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 25% ± 7% | |
endothelial cell of lymphatic vessel | 8 studies | 30% ± 8% | |
endothelial cell of artery | 3 studies | 24% ± 2% | |
epithelial cell | 3 studies | 31% ± 8% | |
vein endothelial cell | 3 studies | 30% ± 12% | |
macrophage | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of SELENON at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 7966.15 | 180 / 180 | 100% | 102.81 | 430 / 430 |
pancreas | 100% | 5175.50 | 328 / 328 | 100% | 68.31 | 178 / 178 |
prostate | 100% | 9273.29 | 245 / 245 | 100% | 145.91 | 502 / 502 |
skin | 100% | 7705.25 | 1809 / 1809 | 100% | 168.63 | 472 / 472 |
brain | 100% | 4586.39 | 2636 / 2642 | 100% | 129.35 | 704 / 705 |
esophagus | 100% | 6877.30 | 1445 / 1445 | 99% | 117.48 | 182 / 183 |
breast | 100% | 10144.26 | 459 / 459 | 99% | 95.77 | 1109 / 1118 |
thymus | 100% | 9240.62 | 653 / 653 | 99% | 77.17 | 600 / 605 |
lung | 100% | 8525.00 | 578 / 578 | 99% | 86.60 | 1144 / 1155 |
uterus | 100% | 8143.99 | 170 / 170 | 98% | 65.69 | 452 / 459 |
stomach | 100% | 5564.79 | 359 / 359 | 98% | 93.33 | 281 / 286 |
intestine | 100% | 5824.38 | 965 / 966 | 98% | 68.36 | 518 / 527 |
bladder | 100% | 7379.90 | 21 / 21 | 98% | 71.63 | 492 / 504 |
kidney | 100% | 6894.71 | 89 / 89 | 94% | 51.54 | 850 / 901 |
adrenal gland | 100% | 7137.79 | 258 / 258 | 86% | 31.54 | 198 / 230 |
liver | 67% | 1352.83 | 151 / 226 | 70% | 24.77 | 286 / 406 |
adipose | 100% | 9846.88 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 113.41 | 80 / 80 |
spleen | 100% | 6386.81 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 57.69 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.34 | 1 / 1 |
blood vessel | 100% | 5978.49 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 5472.23 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 4871.90 | 858 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 24.30 | 23 / 29 |
peripheral blood | 40% | 675.62 | 368 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048741 | Biological process | skeletal muscle fiber development |
GO_0055074 | Biological process | calcium ion homeostasis |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0007005 | Biological process | mitochondrion organization |
GO_1902884 | Biological process | positive regulation of response to oxidative stress |
GO_0014858 | Biological process | positive regulation of skeletal muscle cell proliferation |
GO_0014816 | Biological process | skeletal muscle satellite cell differentiation |
GO_0014873 | Biological process | response to muscle activity involved in regulation of muscle adaptation |
GO_0033555 | Biological process | multicellular organismal response to stress |
GO_0060314 | Biological process | regulation of ryanodine-sensitive calcium-release channel activity |
GO_0003016 | Biological process | respiratory system process |
GO_0014834 | Biological process | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration |
GO_0048286 | Biological process | lung alveolus development |
GO_0071313 | Biological process | cellular response to caffeine |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SELENON |
Protein name | Selenoprotein N Selenoprotein N (SelN) |
Synonyms | SELN SEPN1 |
Description | FUNCTION: [Isoform 2]: Plays an important role in cell protection against oxidative stress and in the regulation of redox-related calcium homeostasis. Regulates the calcium level of the ER by protecting the calcium pump ATP2A2 against the oxidoreductase ERO1A-mediated oxidative damage. Within the ER, ERO1A activity increases the concentration of H(2)O(2), which attacks the luminal thiols in ATP2A2 and thus leads to cysteinyl sulfenic acid formation (-SOH) and SEPN1 reduces the SOH back to free thiol (-SH), thus restoring ATP2A2 activity . Acts as a modulator of ryanodine receptor (RyR) activity: protects RyR from oxidation due to increased oxidative stress, or directly controls the RyR redox state, regulating the RyR-mediated calcium mobilization required for normal muscle development and differentiation . .; FUNCTION: Essential for muscle regeneration and satellite cell maintenance in skeletal muscle . . |
Accessions | H9KV50 ENST00000494537.2 ENST00000361547.7 [Q9NZV5-1] ENST00000354177.9 ENST00000374315.1 [Q9NZV5-2] Q9NZV5 A0A804HLD6 |